透過您的圖書館登入
IP:18.118.121.55
  • 期刊

不同產地餘甘子提取物抗發炎效果之研究

Study on the Anti-inflammatory Effects of Extracts of Phyllanthus Emblica from Different Origins

摘要


本研究選擇中國雲南、印度古吉拉特邦以及柬埔寨金邊,三個地區所生產的餘甘子(Phyllanthus emblica L.)為材料,研究其提取物對細胞抗發炎的「應答效果」。本研究以三種(常見/主要)促炎因子,包含:「一氧化氮(nitric oxide, NO)」、「白介素 6(interleukin 6, IL-6)」和「腫瘤壞死因子-α(tumor necrosis factor-alpha, TNF-α)」進行分析,並探討餘甘子提取物是否具有細胞毒性(microculture tetrazolium assay, MTT assay)。分析結果顯示,三個地區產出的餘甘子提取物,具有顯著抑制NO與IL-6產生的抗炎應答效果,但對TNF-α無顯著的抑制作用;同時,並未測得對細胞產生毒性。本研究結果,可以提供餘甘子做為抗發炎原料在產地來源選擇上決策的依據,以及商業化生產行銷的重要參考。

關鍵字

餘甘子 炎性因子 巨噬細胞

並列摘要


This study used emblica fruit (Phyllanthus emblica L.) extractions from Yunnan, China, Gujarat, India and Phnom Penh, Cambodia as materials to explore its anti-inflammatory response effect on cells. Causing inflammation of three factors, include nitric oxide (NO), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), be tested and cytotoxicity (microculture tetrazolium assay, MTT assay) be analyzed. The results showed that the three of Phyllanthus emblica extraction have significantly inhibited effect on NO and IL-6. But it has no inhibitory effect on TNF-α. Meanwhile, cytotoxicity did not be detected at this study. This study can provide a gate for follower of emblica fruit to further research.

參考文獻


林文宏、董其樺,2021,印度餘甘子提取物抑制發炎作用之研究,生物產業科技管理叢刊,9:84-95,DOI:10.6170/BTMR.202104_9.0006.
盧俊吉、張登豊、林文宏、陳冠興、顏德隆、林庭寬,2020,余甘子對抗發炎功效之探討,生物產業科技管理叢刊,8:1 - 22,DOI:10.6170/BTMR.202004_8.0001.
Chaikul P, Kanlayavattanakul M, Somkumnerd J, Lourith N. 2021. Phyllanthus emblica L. (amla) branch: A safe and effective ingredient against skin aging. J Tradit Complement Med, 11(5):390-399. doi: 10.1016/j.jtcme.2021.02.004.
楊順楷、楊亞力、楊維力,2008,余甘子資源植物的研究與開發進展,應用與環境生物學報,14 ( 6 ): 846~854,DOI: 10.3724/SP.J.1145.2008.00846.
Kunchana K, Jarisarapurin W, Chularojmontri L, Wattanapitayakul S K. 2021. Potential Use of Amla (Phyllanthus emblica L.) Fruit Extract to Protect Skin Keratinocytes from Inflammation and Apoptosis after UVB Irradiation. Antioxidants (Basel), 10(5):703. doi: 10.3390/antiox10050703.

延伸閱讀